The National Medical Fellowships Doctors in Clinical Trials Research program (NMF DCTR) trains physicians who are committed to investigating treatment and preventative regimens across all populations to lead clinical research. The mission of the NMF DCTR is to increase patient engagement and participation in clinical research and to improve health outcomes by ensuring the safety and efficacy of drug treatments and therapeutics for all intended target populations.
NMF DCTR candidates must meet the following eligibility criteria:
•Hold the degree of M.D., M.D./Ph. D., D.O., D.O./Ph. D., or Pharm.D.
•Are a U.S. citizen or lawful permanent resident (LPR) as defined by the U.S. Department of Homeland Security. (NOTE: J-1, O-1 & H-1B visa holders are eligible; the visa must be valid during the eight-week investigator certification training program period.)
•Have an active and unrestricted U.S. medical or pharmacy license*
•Affirm availability to participate in the full eight-week training program
•Demonstrated and continuing commitment to serving medically underserved communities
*ICH-GCP Section 4.1, Investigator’s Qualifications and Agreements, outlines the minimum qualifications to serve as an investigator on a clinical trial involving human subjects. To earn the Parexel Academy Clinical Investigator Certificate, participants must possess active, unrestricted U.S. medical licenses.
NMF DCTR participants are therefore required to possess active, unrestricted U.S. medical licenses at the time of certification. Please note that residents are able to apply if they will receive their medical license within six months of the end date of the applicable cohort. Paraxel will hold the certificate until the U.S medical license is obtained.
For all questions and application inquiries, please contact NMFDrinfo@nmfonline.org.
2026 March Cohort NMF DCTR
The National Medical Fellowships Doctors in Clinical Trials Research program (NMF DCTR) trains physicians who are committed to investigating treatment and preventative regimens across all populations to lead clinical research. The mission of the NMF DCTR is to increase patient engagement and participation in clinical research and to improve health outcomes by ensuring the safety and efficacy of drug treatments and therapeutics for all intended target populations.
NMF DCTR candidates must meet the following eligibility criteria:
•Hold the degree of M.D., M.D./Ph. D., D.O., D.O./Ph. D., or Pharm.D.
•Are a U.S. citizen or lawful permanent resident (LPR) as defined by the U.S. Department of Homeland Security. (NOTE: J-1, O-1 & H-1B visa holders are eligible; the visa must be valid during the eight-week investigator certification training program period.)
•Have an active and unrestricted U.S. medical or pharmacy license*
•Affirm availability to participate in the full eight-week training program
•Demonstrated and continuing commitment to serving medically underserved communities
*ICH-GCP Section 4.1, Investigator’s Qualifications and Agreements, outlines the minimum qualifications to serve as an investigator on a clinical trial involving human subjects. To earn the Parexel Academy Clinical Investigator Certificate, participants must possess active, unrestricted U.S. medical licenses.
NMF DCTR participants are therefore required to possess active, unrestricted U.S. medical licenses at the time of certification. Please note that residents are able to apply if they will receive their medical license within six months of the end date of the applicable cohort. Paraxel will hold the certificate until the U.S medical license is obtained.
For all questions and application inquiries, please contact NMFDrinfo@nmfonline.org.